Items per page
Sort by

Send to:

Choose Destination

Results: 15


Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients.

Oberguggenberger A, Goebel G, Beer B, Oberacher H, Meraner V, Sztankay M, Sperner-Unterweger B, Zeimet AG, Marth C, Hubalek M, Holzner B.

Breast J. 2014 Sep-Oct;20(5):555-7. doi: 10.1111/tbj.12323. Epub 2014 Jul 8. No abstract available.


Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.

Hubalek M, Oberguggenberger A, Beer B, Meraner V, Sztankay M, Oberacher H, Schubert B, Wildt L, Seeber B, Giesinger J, Kemmler G, Holzner B, Sperner-Unterweger B.

Clin Breast Cancer. 2014 Aug;14(4):291-6. doi: 10.1016/j.clbc.2013.12.008. Epub 2013 Dec 27.


The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.

Gamper EM, Groenvold M, Petersen MA, Young T, Costantini A, Aaronson N, Giesinger JM, Meraner V, Kemmler G, Holzner B; EORTC Quality of Life Group.

Psychooncology. 2014 Apr;23(4):397-403. doi: 10.1002/pon.3427. Epub 2013 Nov 11.


Quality of life during chemotherapy in lung cancer patients: results across different treatment lines.

Wintner LM, Giesinger JM, Zabernigg A, Sztankay M, Meraner V, Pall G, Hilbe W, Holzner B.

Br J Cancer. 2013 Oct 29;109(9):2301-8. doi: 10.1038/bjc.2013.585. Epub 2013 Oct 3.


Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.

Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M.

BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474.


Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.

Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sztankay M, Zeimet AG, Sperner-Unterweger B, Holzner B.

BMC Cancer. 2012 Feb 28;12:77. doi: 10.1186/1471-2407-12-77.


CYP2D6 genotyping in breast cancer patients by liquid chromatography-electrospray ionization mass spectrometry.

Beer B, Plattner S, Hubalek M, Oberguggenberger A, Sztankay M, Meraner V, Achleitner R, Oberacher H.

Horm Mol Biol Clin Investig. 2011 Oct 1;6(3):247-53. doi: 10.1515/HMBCI.2011.015.


Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).

Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, Giesinger J, Kemmler G, Egle D, Gamper EM, Sperner-Unterweger B, Holzner B.

Breast Cancer Res Treat. 2011 Jul;128(2):553-61. doi: 10.1007/s10549-011-1378-5. Epub 2011 Feb 11.


Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.

Sperner-Unterweger B, Neurauter G, Klieber M, Kurz K, Meraner V, Zeimet A, Fuchs D.

Immunobiology. 2011 Mar;216(3):296-301. doi: 10.1016/j.imbio.2010.07.010. Epub 2010 Aug 19.


Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.

Beer B, Schubert B, Oberguggenberger A, Meraner V, Hubalek M, Oberacher H.

Anal Bioanal Chem. 2010 Oct;398(4):1791-800. doi: 10.1007/s00216-010-4075-z. Epub 2010 Aug 22.


Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients.

Meraner V, Giesinger J, Kemmler G, Taucher S, Hubalek M, Weber B, Rumpold G, Sperner-Unterweger B, Holzner B.

Psychooncology. 2009 Sep;18(9):974-83. doi: 10.1002/pon.1480.


Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication.

Giesinger J, Kemmler G, Meraner V, Gamper EM, Oberguggenberger A, Sperner-Unterweger B, Holzner B.

Breast Care (Basel). 2009;4(3):148-154. Epub 2009 Jun 26.


Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls.

Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP, Nachbaur D.

Eur J Haematol. 2005 Apr;74(4):304-8.


Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors.

Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B.

Acta Oncol. 2004;43(2):153-60.


Fatigue in ovarian carcinoma patients: a neglected issue?

Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T, Nguyen-Van-Tam D, Zeimet AG, Fleischhacker WW, Sperner-Unterweger B.

Cancer. 2003 Mar 15;97(6):1564-72.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk